Omega 3 fatty acids and cerebral neurotransmission;Oméga 3 et neurotransmission cérébrale

OCL - Oleagineux Corps Gras Lipides

Volumn 11, Issue 1, 2004, Pages 58-65

  Vancassel, Sylvie ^a  

^a CEMAGREF   (France)

Author keywords

Brain; Neurotransmission; Omega 3 fatty acids

Indexed keywords

ANIMALIA;

EID: 3042691233     PISSN: 12588210     EISSN: None     Source Type: Journal    
DOI: 10.1051/ocl.2004.0058     Document Type: Review

References (95)

1. AÏD S, VANCASSEL S, POUMÈS-BALLIHAUT C, CHALON S, GUESNET P, LAVIALLE M. Effect of a diet-induced (n-3) polyunsaturated fatty acid depletion on cholinergic parameters in the rat hippocampus. J Lipid Res 2003 ; 44 : 1545-51.
2. BOURRE JM, FRANÇOIS M, YOUYOU A, et al. The effects of dietary α-linolenic acid on the composition of nerve membranes, enzymatic activity, amplitude of electrophysiological parameters, resistance to poison and performance of learning tasks in rats. J Nutr 1989 ; 119 : 1880-92.
3. CARRIÉ I, CLÉMENT M, DE JAVEL D, FRANCÈS H, BOURRE JM. Phospholipid supplementation reverses behavioral and biochemical alterations induced by n-3 polyunsaturated fatty acid deficiency in mice. J Lipid Res 2000 ; 41 : 473-80.
4. DELION S, CHALON S, GUILLOTEAU D, BESNARD JC, DURAND C. α -linolenic acid dietary deficiency alters age-related changes of dopaminergic and serotoninergic neurotransmission in the rat frontal cortex. J Neurochem 1996 ; 66 : 1582-91.
5. FAVRELIÈRE S, BARRIER L, DURAND G, CHALON S, TALLINEAU C. Chronic dietary n-3 polyunsaturated fatty acids deficiency affects the fatty acid composition of plasmenylethanolamine and phosphatidylethanolamine differently in rat frontal cortex, striatum and cerebellum. Lipids 1998 ; 33 : 401-7.
6. LAURITZEN L, HANSEN HS, JORGENSEN MH, MICHAELSEN KF. The essentiality of long chain n-3 fatty acids in relation to development and function of the brain and retina. Prog Lipid Res 2001 ; 40 : 1-94.
7. NEURINGER M, CONNOR WE, LIN DS, BARSTAD L, LUCK SJ. Biochemical and functional effects of prenatal and postnatal oméga 3 fatty acid deficiency on retina and brain in rhesus monkeys. Proc Natl Acad USA 1986 ; 83 : 4021-5.
8. WAINWRIGHT PE. Do essential fatty acids play a role in brain and behavioral development ? Neurosci Behav Rev 1992 ; 16 : 193-205.
9. CUNNANE SC, FRANCESCUTTI V, BRENNA JT, CRAWFORD M. Breast-fed infants achieve a higher rate of brain and whole body docosahexaenoate accumulation than formula-fed infants not consuming dietary docosahexaenoate. Lipids 2000 ; 35 : 105-11.
10. YONEKUBO A. Physiological role of fatty acids in infancy : effect of dietary fat on brain fatty acids and learning ability in infancy, in Handbook of Essential Fatty Acid Biology : Biochemistry, Physiology, and Behavioral Neurobiology, Yehuda S and Mostofsky DI, Humana Press Inc, Ttotowa, 1997 ; 361-96.
11. ALESSANDRI JM, GOUSTARD B, GUESNET P, DURAND G. Docosahexaenoic acid concentrations in retinal phospholipids of piglets fed an infant formula enriched with long-chain polyunsaturated fatty acids : effects of egg phospholipids and fish oils with different ratios of eicosapentaenoic acid to docosahexaenoic acid. Am J Clin Nutr 1998 ; 67 : 377-85.
12. REISBICK S, NEURINGER M. Omega-3 fatty acid deficiency and behavior : a critical review and directions for future research, in Handbook of Essential Fatty Acid Biology : Biochemistry, Physiology, and Behavioral Neurobiology, Yehuda S and Mostofsky DI, Humana Press Inc, Totowa, 1997 ; 397-426.
13. MORIGUCHI T, SHEAFF GREINER R, SALEM N. Behavioral deficits associated with dietary induction of decreased brain docosahexaenoic acid concentration. J Neurochem 2000 ; 75 : 2563-73.
14. SHEAFF GREINER R, MORIGUSHI T, HUTTON A, SLOTNICK BM, SALEM N. Rats with low levels of brain docosahexaenoic acid show impaired performance in olfactory-base and spatial learning tasks. Lipids 1999 ; 34 : S239-243.
15. FRANCÈS H, MONIER C, CLEMENT M, LECORSIER A, DEBRAY M, BOURRE JM. Effect of dietary alpha-linolenic acid deficiency on habituation. Life Sci 1996 ; 58 : 1805-6.
16. ENSLEN M, MILLON H, MALNOE A. Effect of a low intake of n-3 fatty acids during development on brain phospholipid fatty acid composition and exploratory behavior in rats. Lipids 1991 ; 26 : 203-8.
17. CATALAN J, MORIGUCHI T, BSLOTNICK B, M MURTHY, SHEAFF GREINER R, SALEM N. Cognitive deficits in docosahexaenoic acid-deficient rats. Behav Neurosc 2002 ; 116 : 1022-31.
18. YEHUDA S, LEPROHON-GREENWOOD CE, DIXON LM, COSCINA DV. Effects of dietary fat on pain threshold, thermoregulation and motor activity in rats. Pharmacol Biochem Behav 1986 ; 24 : 1775-7.
19. YAMAMOTO N, HASHIMOTO A, TAKEMOTO Y, et al. Effect of dietary alpha-linolenate/linoleate balance on brain lipid compositions and learning ability of rats. II : Discrimination process, extinction process, and glycolipid compositions. J Lipid Res 1988 ; 29 : 1013-21.
20. REISBICK S, NEURINGER M, HASNAIN R, CONNOR WE. Polydipsia in rhesus monkeys deficient in oméga-3 fatty acids. Physiol Behav 1990 ; 47 : 315-23.
21. REISBICK S, M. NEURINGER, HASNAIN R, CONNOR WE. Home cage behavior of rhesus monkeys with long-term deficiency of oméga - 3 fatty acids. Physiol Behav 1994 ; 55 : 213-39.
22. IKEMOTO A, OHISHI M, SATO Y, et al. Reversibility of n-3 fatty acid deficiency-induced alterations of learning behavior in the rat : level of n-6 fatty acids as another critical factor. J Lipid Res 2001 ; 42 : 1655-63.
23. MORIGUSHI T, SALEM N. Recovery of brain docosahexaenoate leads to recovery of spatial task performance. J Neurochem 2003 ; 87 : 297-309.
24. DRATZ EA, HOLTE LL. The molecular spring model for the function of docosahexaenoic acid (22 :6 ω -3) in biological membranes, in Essential fatty acids and eicosanoids, Sinclair A. et Gibson R, AOCS, Champaign, 1992 ; 122-7.
25. TREEN M, UAUY RD, JAMESON DM, THOMAS VL, HOFFMAN DR. Effect of docosahexaenoic acid on membrane fluidity and function in intact cultured Y-79 retinoblastoma cells. Arch Biochem Biophys 1992 ; 294 : 564-70
26. BROWN M, GIBSON N. Biological function of docosahexaenoic acid in the retinal rod disk membrane, in Essential fatty acids and eicosanoids. Sinclair A et Gibson R, AOCS, Champaign, 1992 ; 134-8.
27. GERBI A, ZEROUGA M, DEBRAY M, DURAND G, CHANEZ C, BOURRE JM. Effect of fish oil diet on fatty acid composition of phospholipids of brain membranes and on kinetic properties of Na +, K(+)-ATPase isoenzymes of weaned and adult rats. J Neurochem 1994 ; 62 : 1560-9.
28. SUN GY, SUN AY. Synaptosomal plasma membranes : acyl group composition of phosphoglycerides and (Na + plus K +)-ATPase activity during fatty acid deficiency. J Neurochem 1974 ; 22 : 15-8.
29. XIMENES DA SILVA A, LAVIALLE F, GENDROT G, GUESNET P, ALESSANDRI JM, LAVIALLE M. Glucose transport and utilization are altered in the brain of rats deficient in n-3 polyunsaturated fatty acids. J Neurochem 2002 ; 81 : 1328-37.
30. WOLFE LS, HORROCKS L. Eicosanoids, in Basic Neurochemistry. Siedel GJ, Agranoff BW, Albers RW and Molinoff PB, Raven Press (USA), 1994 ; 475-92.
31. DE LA PRESA OWENS S, INNIS S. Docosa-hexaenoic and arachidonic acid prevent a decrease in dopaminergic and serotoninergic neurotransmitters in frontal cortex caused by a linoleic and α-linolenic acid deficient diet in formula-fed piglets. J Nutr 1999 ; 129 : 2088-93.
32. DE LA PRESA OWENS S, INNIS S. Diverse, region-specific effects of addition of arachidonic and docosahexaenoic acids to formula with low or adequate linoleic and α-linolenic acids on piglet brain monoaminergic neurotransmitters. Pediatr Res 2000 ; 48 : 125-30.
33. NG KF, INNIS S. Behavioral responses are altered in piglets with decreased frontal cortex docosahexaenoic acid. J Nutr 2003 ; 133 : 3222-7.
34. CHALON S, VANCASSEL S, ZIMMER L, GUILLOTEAU D, DURAND G. PUFA and cerebral function : focus on monoaminergic neurotransmitters. Lipids 2001 ; 36 : 937-44.
35. DELION S, CHALON S, GUILLOTEAU D, LEJEUNE B, BESNARD JC, DURAND G. Age-related changes in phospholipid fatty acid composition and monoaminergic neurotransmission in the hippocampus of rats fed a balanced or an n-3 polyunsaturated fatty acid deficient diet. J Lipid Res 1997 ; 38 : 680-9.
36. DELION S, CHALON S, HÉRAULT J, GUILLOTEAU D, BESNARD JC, DURAND G. Chronic dietary α-linolenic acid deficiency alters dopaminergic and serotoninergic neurotransmission in rats. J Nutr 1994 ; 124 : 2466-76.
37. ZIMMER L, DELION-VANCASSEL S, BRETON P, et al. The dopamine mesocorticolimbic pathway is altered by a chronic deficiency in n-3 polyunsaturated fatty acids in the rat. Am J Clin Nutr 2002 ; 75 : 662-7.
38. ZIMMER L, DELION-VANCASSEL S, DURAND G, et al. Modification of dopamine neurotransmission in the nucleus accumbens of rats deficient in n-3 polyunsaturated fatty acids. J Lipid Res 2000 ; 41 : 32-40.
39. KODAS E, VANCASSEL S, LEJEUNE B, GUILLOTEAU D, CHALON S. Reversibility of (n-3) fatty acid deficiency-induced changes in dopaminergic neurotransmission in rats : critical role of developmental stage. J Lipid Res 2002 ; 43 : 1209-19.
40. MINAMI M, KIMURA S, ENDO T, et al. Dietary docosahexaenoic acid increases cerebral acetylcholine levels and improves passive avoidance performance in stoke-prone spontaneously hypertensive rats. Pharmacol Biochem Behav 1997 ; 58 : 1123-9.
41. FENTON WS, HIBBELN J, KNABLE M. Essential fatty acids, lipid membrane abnormalities, and the diagnosis and treatment of Schizophrenia. Biol Psychiatry 2000 ; 47 : 8-21.
42. HORROBIN DF, MANKU MS, HILLMAN H, IAIN A, GLEN M. Fatty acid levels in the brains of schizophrenics and normal controls. Biol Psychiatry 1991 ; 30 : 795-805.
43. PEET M. Eicosapentaenoic acid in the treatment of schizophrenia and depression : rationale and preliminary double-blind clinical trial results. Prostaglandins, Leukotrienes and Essential Fatty Acids 2003 ; 69 : 477-85.
44. MAES M, CHRISTOPHE A, DELANGHE J, ALTAMURA C, NEELS H, MELTZER HY. Lowered ω3 polyunsaturated fatty acids in serum phospholipids and cholesteryl esters of depressed patients. Psychiatry Res 1999 ; 85 : 275-91.
45. MAES M, SMITH R, CHRISTOPHE A, COSYNS P, DESNYDER R, MELTZER H. Fatty acid composition in major depression : decreased ω3 fractions in cholesteryl esters and increased C20:4 ω6/C20:5 ω3 ratio in cholesteryl esters and phospholipids. J Affect Disord 1996 ; 38 : 35-46.
46. BURGESS JR, STEVENS L, ZHANG W, PECK L. Long-chain polyunsaturated fatty acids in children with attention-deficit hyperactivity disorder. Am J Clin Nutr 2000 ; 71 : 327-30.
47. PEET M, GLEN I, HORROBIN. Phospholipid spectrum disorder in psychiatry. Marius Press, Carnforth, UK 1999.
48. GLEN AIM, GLEN EMT, HORROBIN D, et al. A red cell membrane abnormality in a subgroup of schizophrenic patients : Evidence for two diseases. Schizophr Res 1994 ; 12 : 53-61.
49. PEET M, LAUGHARNE JDE, RANGARAJAN N, HORROBIN D, REYNOLDS G. Depleted red cell membrane essential fatty acids in drug-treated schizophrenic patients. J Psychiatry Res 1995 ; 29 : 227-32.
50. YAO JK, VAN KAMMEN DP, WELKER JA. Red blood cell membrane dynamics in schizophrenia. II. Fatty acid composition. Schizophr Res 1994 ; 13 : 216-26.
51. YAO JK, LEONARD S, REDDY RD. Membranes phospholipid abnormalities in postmortem brains from schizophrenic patients. Schizophrenia Res 2000 ; 42 : 7-17.
52. LAUGHARNE JD, MELLOR JE, PEET M. Fatty acids and schizophrenia. Lipids 1996 ; 31 : S163-165.
53. GATTAZ WF, HÜBNER CK, NEVALAINEN TJ, THUREN T, KINNUNEN PKJ. Increased serum phospholipase A2 activity in schizophrenia : a replication study. Biol Psychiatry 1990 ; 28 : 495-501.
54. GATTAZ WF, KÖLLISH M, THUREN T, VIRTANEN JA, KINNUNEN PKJ. Increased plasma phospholipase A2 activity in schizoprenic patients : reduction after neuroleptic therapy. Biol Psychiatry 1987 ; 22 : 421-6.
55. GATTAZ WF, STEUDLE A, MARAS A. Increased platelet phospholipase A2 activity in schizophrenia. Schizophr Res 1995 ; 16 : 1-6.
56. HORROBIN DF. The membrane phospholipid hypothesis as a biochemical basis for the neurodevelopmental concept of schizophrenia. Schizophr Res 1998 ; 30 : 193-208.
57. HORROBIN DF, GLEN AIM, VADDADI K. The membrane hypothesis of schizophrenia. Schizophrenia Res 1994 ; 13 : 195-207.
58. 31P-MR spectroscopy study. Schizophrenia Res 1994 ; 13 : 209-15.
59. REDDY R, KESHAVAN MS. Phosphorus magnetic resonance spectroscopy : its utility in examining the membrane hypothesis of schizophrenia. Prostaglandins, Leukotrienes and Essential Fatty Acids 2003 ; 69 : 401-5.
60. CHRISTENSEN O, CHRISTENSEN E. Fat consumption and schizophrenia. Acta Psychiatr Scand 1988 ; 78 : 587-91.
61. MELLOR JE, LAUGHARNE JDE, PEET M. Omega-3 fatty acid supplementation in schizophrenic patients. Human Psychopharmacol 1996 ; 11 : 39-46.
62. PEET M, BRIND J, RAMCHAND CN, SHAH S, VANKAR GK. Two double-blind placebo-controlled pilot studies of eicosapentaenoic acid in the treatment of schizophrenia. Schizophr Res 2001 ; 49 : 243-51.
63. EMSLEY RA, MYBURGH CC, OOSTHUIZEN PP, VAN RENSBURGH SJ. Randomised placebo-controlled study of ethyl-eicosapentaenoic acid as supplemental treatment in schizophrenia. Am J Psychiatry 2002 ; 159 : 1596-8.
64. PURI BK, RICHARDSON AJ, HORROBIN DF, et al. Eicosapentaenoic acid treatment in schizophrenia associated with symptom remission, normalisation of blood fatty acids, reduced neuronal membrane phospholipid turnover and structural brain changes. Int J Clin Pract 2000 ; 54 : 57-63.
65. SU KP, SHEN WW, HUANG SY. Omega 3 fatty acids as a psychotherapeutic agent for a pregnant schizophrenic patient. Eur Neuropsychopharmacol 2001 ; 11 : 205-9.
66. SEVERUS WE, LITTMAN AB, STOLL AL. Omega-3 fatty acids, homocysteine, and the increased risk of cardiovascular mortality in major depressive disorder. Harv Rev Psychiatry 2001 ; 9 : 280-93.
67. BRUINSMA KA, TAREN DL. Dieting, essential fatty acid intake, and depression. Nutr Rev 2000 ; 58 : 98-108.
68. EDWARDS RH, PEET M, SHAY J, HORROBIN D. Omega-3 polyunsaturated fatty acid levels in the diet and red blood cell membranes of depressed patients. J Affect Disord 1998 ; 48 : 149-55.
69. PEET M, MURPHY B, SHAY J, HORROBIN D. Depletion of oméga-3 fatty acid levels in red blood cell membranes of depressive patients. Biol Psychiatry 1998 ; 43 : 315-9.
70. MAMALAKIS G, TORNARITIS M, KAFATOS A. Depression and adipose essential polyunsaturated fatty acids. Prostaglandins, Leukotrienes and Essential Fatty Acids 2002 ; 67 : 311-8.
71. HIBBELN JR, SALEM N. Dietary polyunsaturated fatty acids and depression : when cholesterol does not satisfy. Am J Clin Nutr 1995 ; 62 : 1-9.
72. HIBBELN JR. Fish consumption and major depression. Lancet 1998 ; 351 : 1213.
73. HIBBELN JR. Long-chain polyunsaturated fatty acids in depression and related conditions, in Phospholipid spectrum disorder, Peet M, Glen I and Horrobin DF, Marius Press, Carnforth, UK, 1999 ; 195-210.
74. TANSKANEN A, HIBBELN JR, HINTIKKA J, HAATAINEN K, HONKALAMPI K, VIINAMAKI R. Fish consumption, depression, and suicidality in a general population. Arch Gen Psychiatry 2001 ; 58 : 512-3.
75. DE VRIESE SR, CHRISTOPHE AB, MAES M. Lowered serum n-3 polyunsaturated fatty acid (PUFA) levels predict the occurence of postpartum depression : further evidence that lowered n-3 PUFAs are related to major depression. Life Sci 2003 ; 73 : 3181-7.
76. HIBBELN JR. Seafood consumption, the DHA content of mother's milk and prevalence rates of postpartum depression : a cross-national, ecological analysis. J Affect Disord 2002 ; 69 : 15-29.
77. OTTO SJ, DE GROOT RH, HORNSTRA G. Increased risk of postpartum depressive symptoms is associated with slower normalization after pregnancy of the functional docosahexaenoic acid status. Prostaglandins, Leukotrienes ans Essential Fatty Acids 2003 ; 69 : 237-43.
78. LLORENTE AM, JENSEN CL, VOIGHT RG, FRALEY JK, BERRETTA MC, HEIRD WC. Effect of maternal docosahexaenoic acid supplementation on postapartum depression and information processing. Am J Obstet Gynecol 2003 ; 188 : 1348-53.
79. STOLL AL, LOCKE CA, MARANGELL LB, SEVERUS WE. Omega-3 fatty acids and bipolar disorder : a review. Prostaglandins, Leukotrienes and Essential Fatty Acids 1999 ; 60 : 329-37.
80. PEET M, HORROBIN DF. A dose-ranging study of the effects of ethyl-eicosapentaenoate in patients with ongoing depression despite apparently adequate treatment with standard drugs. Arch Gen Psychiatry 2002 ; 59 : 913-9.
81. NEMETS B, STAHL Z, BELMAKER RH. Addition of oméga-3 fatty acid to maintenance medication treatment for recurrent unipolar depressive disorder. Am J Psychiatry 2002 ; 159 : 477-9.
82. SAGVOLDEN T, AASE H, ZEINER P, BERGER D. Altered reinforcement mechanisms in attention-deficit/hyperactivity disorder. Behav Brain Res 1998 ; 94 : 61-71.
83. FARAONE SV, BIEDERMAN J. Neurobiology of attention-deficit hyperactivity disorder. Biol Psychiatry 1998 ; 44 : 951-8.
84. SAGVOLDEN T, SERGEANT JA. Attention deficit/hyperactivity disorder - from brain dysfunctions to behaviour. Behav Brain Res 1998 ; 94 : 1-10.
85. RUSSELL V, DE VILLIERS A, SAGVOLDEN T, LAMM M, TALJAARD J. Differences between electrically-, ritalin- and D-amphetamine-stimulated release of [3H]dopamine from brain slices suggest impaired vesicular storage of dopamine in an animal model of attention-deficit hyperactivity disorder. Behav Brain Res 1998 ; 94 : 163-71.
86. COLQUOUN I, BUNDAY S. A lack of essential fatty acids as a possible cause of hyperactivity in children. Med Hypotheses 1981 ; 7 : 673-9.
87. MITCHELL EA, AMAN MG, TURBOTT SH, MANKU M. Clinical characteristics and serum essential fatty acid levels in hyperactive children. Clin Pedriatr 1987 ; 26 : 406-11.
88. STEVENS LJ, ZENTALL SS, DECK JL, et al. Essential fatty acid metabolism in boys with attention-deficit hyperactivity disorder. Am J Clin Nutr 1995 ; 62 : 761-8.
89. STEVENS LJ, ZENTALL SS, ABATE ML, KUCZEK T, BURGESS JR. Omega-3 fatty acids in boys with behavior, learning, and health problems. Physiol Behav 1996 ; 59 : 915-20.
90. AMAN MG, MITCHELL EA, TURBOTT SH. The effects of essential fatty acid supplementation by Efamol in hyperactive children. J Abnorm Child Psychol 1987 ; 15 : 75-90.
91. ARNOLD LE, KLEYKAMP D, VOTOLOATO NA, TAYLOR WA, KONTRAS S, TOBIN K. Gamma-linolenic acid for attention-deficit hyperactivity disorder : placebo-controlled comparison to D-amphetamine. Biol Psychiatry 1989 ; 25 : 222-8.
92. VOIGHT R. Attention deficit hyperactivity disorder : observational and interventional studies. NIH workshop on oméga-3 essential fatty acids and psychiatric disorders. National Institues of Health, Bethesda, 1998.
93. RICHARDSON AJ, PURI BK. A randomized double-blind, placebo-controlled study of the effects of supplementation with highly unsaturated fatty acids on ADHD-related symptoms in children with specific learning difficulties. Prog Neuropsychopharmacol Biol Psychiatr 2002 ; 26 : 233-9.
94. VOIGHT RG, LLORENTE AM, JENSEN CL, FRALEY JK, BERRETTA MC, HEIRD WX. A randomized, double-blind, placebo-controlled trial of docosahexaenoic acid supplementation in children with attention-deficit/hyperactivity disorder. J Pediatr 2001 ; 139 : 189-96.
95. AILHAUD G, GUESNET P. Fatty acid composition of fats is an early determinant of childhood obesity : a short review and an opinion. Obesity Reviews (in press) 2003.